EQUITY TRANSACTIONS (Details Narrative) - USD ($)				1 Months Ended	12 Months Ended
	Oct. 04, 2023	Sep. 29, 2022	Mar. 24, 2022	Sep. 30, 2022	Mar. 31, 2024	Mar. 31, 2023
Securities Financing Transaction [Line Items]
Reverse stock split	1-for-10
Common stock, shares authorized					60,000,000	60,000,000
Proceeds from sale of common stock					$ 1,322,383	$ 8,927,211
Additional shares authorized for issuance during period				180,000
Shares available for grant					200,948
Volatility rate minimum						136.10%
Volatility rate maximum						140.00%
Dividend rate						0.00%
Risk-free rate minimum						1.49%
Risk-free rate maximum						2.14%
Weighted average expected volatility						138.07%
Weighted average grant date fair value of stock options granted						$ 61,146
RSUs issued					$ 54,428
Stock option exercises					0	0
Stock-based compensation					$ 1,219,370	$ 1,051,898
Intrinsic value per share					$ 1.68
Unrecognized compensation cost to share based					$ 400,002
Weighted average period					1 year 6 months 25 days
Restricted Stock Units (RSUs) [Member]
Securities Financing Transaction [Line Items]
Number of shares granted					54,428
Terms of awards					The RSUs are subject to vesting in four equal installments, with 25% of the restricted stock units vesting on each of June 30, 2023, September 30, 2023, December 31, 2023, and March 31, 2024, subject in each case to the director’s Continuous Service (as defined in the 2020 Plan), through such dates. Vesting will terminate upon the director’s termination of Continuous Service prior to any vesting date.	The RSUs were subject to vesting in three installments, 50% on September 30, 2022, and 25% on each of December 31, 2022, and March 31, 2023, subject to the recipient's continued service with the Company on each such vesting date.
Unvested stock outstanding					4,885	0
Additional shares authorized for issuance during period						1,800,000
Stock-based compensation					$ 206,250	$ 175,000
Options Held [Member]
Securities Financing Transaction [Line Items]
Stock option grants					0	12,222
Stock-based compensation					$ 1,013,120	$ 876,898
R S U [Member]
Securities Financing Transaction [Line Items]
Weighted average grant date fair value ofRSUs stock options granted					$ 58,333
Director 1 [Member] | Restricted Stock Units (RSUs) [Member]
Securities Financing Transaction [Line Items]
Number of shares granted					11,628
Director 2 [Member] | Restricted Stock Units (RSUs) [Member]
Securities Financing Transaction [Line Items]
Number of shares granted					11,628
Director 3 [Member] | Restricted Stock Units (RSUs) [Member]
Securities Financing Transaction [Line Items]
Number of shares granted					11,628
Eligible Directors Each [Member] | Restricted Stock Units (RSUs) [Member]
Securities Financing Transaction [Line Items]
Number of shares granted						3,425
Newly Appointed Director [Member] | Restricted Stock Units (RSUs) [Member]
Securities Financing Transaction [Line Items]
Number of shares granted						5,137
A T M 2022 Agreement [Member]
Securities Financing Transaction [Line Items]
Aggregate offering price		$ 6,625,000	$ 15,000,000
Securities remained available for sale					$ 5,302,617
Proceeds from sale of common stock					1,322,383	$ 8,927,211
Payment of other stock issuance costs					$ 8,202	$ 27,153
Stock issued new, shares issued					296,056	748,084
Average per share sale price					$ 4.47	$ 11.90
A T M 2022 Agreement [Member] | Hc Wainwright [Member]
Securities Financing Transaction [Line Items]
Payment of stock issuance costs					$ 34,118	$ 229,610